-
1
-
-
0030901014
-
High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: A multivariate analysis of survival for 100 consecutively treated patients
-
Stiff PJ, Bayer R, Kerger C et al. High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patients. J Clin Oncol 1997; 15: 1309-1317.
-
(1997)
J Clin Oncol
, vol.15
, pp. 1309-1317
-
-
Stiff, P.J.1
Bayer, R.2
Kerger, C.3
-
2
-
-
0031766638
-
High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer
-
Holmberg LA, Demirer T, Rowley S et al. High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer. Bone Marrow Transplant 1998; 22: 651-659.
-
(1998)
Bone Marrow Transplant
, vol.22
, pp. 651-659
-
-
Holmberg, L.A.1
Demirer, T.2
Rowley, S.3
-
3
-
-
0030979431
-
High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America
-
Antman KH, Rowlings PA, Vaughan WP et al. High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. J Clin Oncol 1997; 15: 1870-1879.
-
(1997)
J Clin Oncol
, vol.15
, pp. 1870-1879
-
-
Antman, K.H.1
Rowlings, P.A.2
Vaughan, W.P.3
-
4
-
-
0030800390
-
High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer
-
Bensinger WI, Schiffman KS, Holmberg L et al. High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer. Bone Marrow Transplant 1997; 19: 1183-1189.
-
(1997)
Bone Marrow Transplant
, vol.19
, pp. 1183-1189
-
-
Bensinger, W.I.1
Schiffman, K.S.2
Holmberg, L.3
-
5
-
-
0027471156
-
Gene-marking to trace origin of relapse after autologous bone-marrow transplantation
-
Brenner MK, Rill DR, Moen RC et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993; 341: 85-86.
-
(1993)
Lancet
, vol.341
, pp. 85-86
-
-
Brenner, M.K.1
Rill, D.R.2
Moen, R.C.3
-
6
-
-
0028131274
-
Efficacy of synthetic vaccines in the induction of cytotoxic T lymphocytes. Comparison of the costimulating support provided by helper T cells and lipoamino acid
-
Borges E, Wiesmuller KH, Jung G, Walden P. Efficacy of synthetic vaccines in the induction of cytotoxic T lymphocytes. Comparison of the costimulating support provided by helper T cells and lipoamino acid. J Immunol Meth 1994; 173: 253-263.
-
(1994)
J Immunol Meth
, vol.173
, pp. 253-263
-
-
Borges, E.1
Wiesmuller, K.H.2
Jung, G.3
Walden, P.4
-
7
-
-
0030996710
-
Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A
-
Cormier JN, Salgaller ML, Prevette T et al. Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A. Cancer J Sci Am 1997; 3: 37-44.
-
(1997)
Cancer J Sci Am
, vol.3
, pp. 37-44
-
-
Cormier, J.N.1
Salgaller, M.L.2
Prevette, T.3
-
8
-
-
0026650448
-
Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine
-
Kantor J, Irvine K, Abrams S et al. Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine. J Natl Cancer Inst 1992; 84: 1084-1091.
-
(1992)
J Natl Cancer Inst
, vol.84
, pp. 1084-1091
-
-
Kantor, J.1
Irvine, K.2
Abrams, S.3
-
9
-
-
0029042336
-
Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaceinia-CEA vaccine
-
Tsang KY, Zaremba S, Nieroda CA et al. Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaceinia-CEA vaccine. J Natl Cancer Inst 1995; 87: 982-990.
-
(1995)
J Natl Cancer Inst
, vol.87
, pp. 982-990
-
-
Tsang, K.Y.1
Zaremba, S.2
Nieroda, C.A.3
-
10
-
-
0028205790
-
Improved survival in stage III melanoma patients with GM2 antibodies: A randomised trial of adjuvant vaccination with GM2 ganglioside
-
Livingston PO, Wong GY, Adluri S et al. Improved survival in stage III melanoma patients with GM2 antibodies: a randomised trial of adjuvant vaccination with GM2 ganglioside. J Clin Oncol 1994; 12: 1036-1044.
-
(1994)
J Clin Oncol
, vol.12
, pp. 1036-1044
-
-
Livingston, P.O.1
Wong, G.Y.2
Adluri, S.3
-
11
-
-
0027478209
-
Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant
-
MacLean GD, Reddish M, Koganty RR et al. Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant. Cancer Immunol Immunother 1993; 36: 215-222.
-
(1993)
Cancer Immunol Immunother
, vol.36
, pp. 215-222
-
-
MacLean, G.D.1
Reddish, M.2
Koganty, R.R.3
-
12
-
-
0027275052
-
Immune responses of mice and human breast cancer patients following immunisation with synthetic sialyl-Tn conjugated to KLH plus detox adjuvant
-
Longenecker BM, Reddish M, Koganty R, MacLean GD. Immune responses of mice and human breast cancer patients following immunisation with synthetic sialyl-Tn conjugated to KLH plus detox adjuvant. Ann NY Acad Sci 1993; 690: 276-291.
-
(1993)
Ann NY Acad Sci
, vol.690
, pp. 276-291
-
-
Longenecker, B.M.1
Reddish, M.2
Koganty, R.3
MacLean, G.D.4
-
13
-
-
0029873154
-
Antibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic STn vaccine
-
MacLean GD, Reddish MA, Koganty RR, Longenecker BM. Antibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic STn vaccine. J Immunother Emph Tumor Immunol 1996; 19: 59-68.
-
(1996)
J Immunother Emph Tumor Immunol
, vol.19
, pp. 59-68
-
-
MacLean, G.D.1
Reddish, M.A.2
Koganty, R.R.3
Longenecker, B.M.4
-
14
-
-
0029787977
-
Enhancing the effect of THERATOPE STn-KLH cancer vaccine in patients with metastatic breast cancer by pretreatmem with low-dose intravenous cyclophosphamide
-
MacLean GD, Miles DW, Rubens RD et al. Enhancing the effect of THERATOPE STn-KLH cancer vaccine in patients with metastatic breast cancer by pretreatmem with low-dose intravenous cyclophosphamide. J Immunother Emph Tumor Immunol 1996; 19: 309-316.
-
(1996)
J Immunother Emph Tumor Immunol
, vol.19
, pp. 309-316
-
-
MacLean, G.D.1
Miles, D.W.2
Rubens, R.D.3
-
15
-
-
0027768747
-
Synthetic tumor-associated sialyl-Tn antigen as an immunotherapeutic cancer vaccine
-
Longenecker BM, Reddish M, Miles D, MacLean GD. Synthetic tumor-associated sialyl-Tn antigen as an immunotherapeutic cancer vaccine. Vaccine Res 1993; 2: 151-162.
-
(1993)
Vaccine Res
, vol.2
, pp. 151-162
-
-
Longenecker, B.M.1
Reddish, M.2
Miles, D.3
MacLean, G.D.4
-
16
-
-
0022457641
-
Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3
-
Thor A, Ohuchi N, Szpak CA et al. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Cancer Res 1986; 46: 3118-3124.
-
(1986)
Cancer Res
, vol.46
, pp. 3118-3124
-
-
Thor, A.1
Ohuchi, N.2
Szpak, C.A.3
-
17
-
-
0030857022
-
Specificities of anti-sialyl-Tn and anti-Tn monoclonal antibodies generated using novel clustered synthetic glycopeptide epitopes
-
Reddish MA, Jackson L, Koganty RR et al. Specificities of anti-sialyl-Tn and anti-Tn monoclonal antibodies generated using novel clustered synthetic glycopeptide epitopes. Glycoconj J 1997; 14: 549-560.
-
(1997)
Glycoconj J
, vol.14
, pp. 549-560
-
-
Reddish, M.A.1
Jackson, L.2
Koganty, R.R.3
-
18
-
-
0026531757
-
Serum sialyl Tn as an independent predictor of poor prognosis in patients with epithelial ovarian cancer
-
Kobayashi H, Terao T, Kawashima Y. Serum sialyl Tn as an independent predictor of poor prognosis in patients with epithelial ovarian cancer. J Clin Oncol 1992; 10: 95-101.
-
(1992)
J Clin Oncol
, vol.10
, pp. 95-101
-
-
Kobayashi, H.1
Terao, T.2
Kawashima, Y.3
-
19
-
-
0032963634
-
Selection of carbohydrate antigens in human epithelial ovarian cancers as targets for immunotherapy: Serous and mucinous tumors exhibit distinctive patterns of expression
-
Federici MF, Kudryashov V, Saigo PE et al. Selection of carbohydrate antigens in human epithelial ovarian cancers as targets for immunotherapy: serous and mucinous tumors exhibit distinctive patterns of expression. Int J Cancer 1999; 81: 193-198.
-
(1999)
Int J Cancer
, vol.81
, pp. 193-198
-
-
Federici, M.F.1
Kudryashov, V.2
Saigo, P.E.3
-
20
-
-
0027263949
-
Immunohistochemical evaluation of sialosyl-Tn antigens in various ovarian carcinomas
-
Ryuko K, Iwanari O, Kitao M, Moriwaki S. Immunohistochemical evaluation of sialosyl-Tn antigens in various ovarian carcinomas. Gynecol Oncol 1993; 49: 215-224.
-
(1993)
Gynecol Oncol
, vol.49
, pp. 215-224
-
-
Ryuko, K.1
Iwanari, O.2
Kitao, M.3
Moriwaki, S.4
-
21
-
-
0026344051
-
Expression of Tn and sialyl-Tn antigens in tumor tissues of the ovary
-
Inoue M, Ton SM, Ogawa H, Tanizawa O. Expression of Tn and sialyl-Tn antigens in tumor tissues of the ovary. Am J Clin Pathol 1991; 96: 711-716.
-
(1991)
Am J Clin Pathol
, vol.96
, pp. 711-716
-
-
Inoue, M.1
Ton, S.M.2
Ogawa, H.3
Tanizawa, O.4
-
22
-
-
0028075832
-
Expression of sialyl-Tn predicts the effect of adjuvant chemotherapy in node-positive breast cancer
-
Miles DW, Happerfield LC, Smith P et al. Expression of sialyl-Tn predicts the effect of adjuvant chemotherapy in node-positive breast cancer. Br J Cancer 1994; 70: 1272-1275.
-
(1994)
Br J Cancer
, vol.70
, pp. 1272-1275
-
-
Miles, D.W.1
Happerfield, L.C.2
Smith, P.3
-
23
-
-
0029743771
-
+ lymphocytes correlate with effects of Theratope sialyl-Tn-KLH cancer vaccine in active specific immunotherapy
-
+ lymphocytes correlate with effects of Theratope sialyl-Tn-KLH cancer vaccine in active specific immunotherapy. Cancer Immunol Immunother 1996; 42: 303-309.
-
(1996)
Cancer Immunol Immunother
, vol.42
, pp. 303-309
-
-
Reddish, M.A.1
MacLean, G.D.2
Poppema, S.3
-
24
-
-
0029017886
-
+ activation antigens on peripheral blood lymphocyte populations in metastatic breast and ovarian cancer patients: Correlations with survival following active specific immunotherapy
-
+ activation antigens on peripheral blood lymphocyte populations in metastatic breast and ovarian cancer patients: correlations with survival following active specific immunotherapy. Int J Cancer 1995; 61: 470-474.
-
(1995)
Int J Cancer
, vol.61
, pp. 470-474
-
-
Yacyshyn, M.B.1
Poppema, S.2
Berg, A.3
-
25
-
-
0029804156
-
A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer
-
Miles DW, Towlson KE, Graham R et al. A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer. Br J Cancer 1996; 74: 1292-1296.
-
(1996)
Br J Cancer
, vol.74
, pp. 1292-1296
-
-
Miles, D.W.1
Towlson, K.E.2
Graham, R.3
-
26
-
-
0026596442
-
Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigen
-
MacLean GD, Samuel J, Meikle A et al. Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigen. J Immunother 1992; 11: 292-305.
-
(1992)
J Immunother
, vol.11
, pp. 292-305
-
-
MacLean, G.D.1
Samuel, J.2
Meikle, A.3
-
27
-
-
0023489992
-
T cell recognition of a tumor-associated glycoprotein and its synthetic carbohydrate epitopes: Stimulation of anticancer T cell immunity in vivo
-
Henningsson CM, Selvaras S, MacLean GD et al. T cell recognition of a tumor-associated glycoprotein and its synthetic carbohydrate epitopes: stimulation of anticancer T cell immunity in vivo. Cancer Immunol Immunother 1987; 25: 231-241.
-
(1987)
Cancer Immunol Immunother
, vol.25
, pp. 231-241
-
-
Henningsson, C.M.1
Selvaras, S.2
MacLean, G.D.3
-
28
-
-
0030854842
-
T-cell recognition of tumor-associated carbohydrates: The nature of the glycan moiety plays a decisive role in determining glycopeptide immunogenicity
-
Galli-Stampino L, Meinjohanns E, Frische K et al. T-cell recognition of tumor-associated carbohydrates: the nature of the glycan moiety plays a decisive role in determining glycopeptide immunogenicity. Cancer Res 1997; 57: 3214-3222.
-
(1997)
Cancer Res
, vol.57
, pp. 3214-3222
-
-
Galli-Stampino, L.1
Meinjohanns, E.2
Frische, K.3
-
29
-
-
0031914321
-
Cancer-associated MUCI mucin inhibits human T-cell proliferation, which is reversible by IL-2
-
Agrawal B, Krantz MJ, Reddish MA, Longenecker BM. Cancer-associated MUCI mucin inhibits human T-cell proliferation, which is reversible by IL-2. Nature Med 1998; 4: 43-49.
-
(1998)
Nature Med
, vol.4
, pp. 43-49
-
-
Agrawal, B.1
Krantz, M.J.2
Reddish, M.A.3
Longenecker, B.M.4
-
30
-
-
0000021742
-
Immunological reconstitution after hemopoietic stem cell transplantation
-
Atkinson K (ed). Cambridge University Press: Cambridge, UK
-
Storek J, Witherspoon RP. Immunological reconstitution after hemopoietic stem cell transplantation. In: Atkinson K (ed). Clinical Bone Marrow and Blood Stem Cell Transplantation: A Reference Textbook. Cambridge University Press: Cambridge, UK, 2000, pp 111-146.
-
(2000)
Clinical Bone Marrow and Blood Stem Cell Transplantation: A Reference Textbook
, pp. 111-146
-
-
Storek, J.1
Witherspoon, R.P.2
-
31
-
-
0032943932
-
Evidence of a cellular immune response against sialyl-Tn in breast and ovarian cancer patients after high-dose chemotherapy, stem cell rescue, and immunization with theratope STn-KLH cancer vaccine
-
Sandmaier BM, Oparin DV, Holmberg LA et al. Evidence of a cellular immune response against sialyl-Tn in breast and ovarian cancer patients after high-dose chemotherapy, stem cell rescue, and immunization with theratope STn-KLH cancer vaccine. J Immunother 1999; 22: 54-66.
-
(1999)
J Immunother
, vol.22
, pp. 54-66
-
-
Sandmaier, B.M.1
Oparin, D.V.2
Holmberg, L.A.3
-
33
-
-
0026693788
-
Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients
-
Barra A, Cordonnier C, Preziosi MP et al. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients. J Infect Dis 1992; 166: 1021-1028.
-
(1992)
J Infect Dis
, vol.166
, pp. 1021-1028
-
-
Barra, A.1
Cordonnier, C.2
Preziosi, M.P.3
-
34
-
-
0021338386
-
Recovery of in vivo cellular immunity after human marrow grafting: Influence of time postgrafting and acute graft-versus-host disease
-
Witherspoon RP, Matthews D, Storb R et al. Recovery of in vivo cellular immunity after human marrow grafting: influence of time postgrafting and acute graft-versus-host disease. Transplantation 1984; 37: 145-150.
-
(1984)
Transplantation
, vol.37
, pp. 145-150
-
-
Witherspoon, R.P.1
Matthews, D.2
Storb, R.3
-
35
-
-
0025347511
-
Reconstruction of the haemopoietic and immune systems after marrow transplantation
-
Atkinson K. Reconstruction of the haemopoietic and immune systems after marrow transplantation (review). Bone Marrow Transplant 1990; 5: 209-226.
-
(1990)
Bone Marrow Transplant
, vol.5
, pp. 209-226
-
-
Atkinson, K.1
|